Corporate Profile
| Corporate Name |
English: intellim Korea Corporation Korean: 주식회사 인텔림코리아 Japanese: 株式会社インテリム コリア |
|---|---|
| Address | #1211, 310, Teheran-ro, Gangnam-gu, 06211 Seoul, Korea |
| CEO | Masakuni Ukita |
| Founded | September 19, 2012 |
| Services | Consulting services and Clinical trial in pharmaceuticals |
intellim Corporation Group Profile
| Corporate Name | intellim Corporation |
|---|---|
| Tokyo Head Office | 5F, ORIX Ueno 1-chome Bldg., 1-1-10 Ueno, Taito-ku, Tokyo, Japan |
| Main Office | Mainichi Intecio 18F, 3-4-5 Umeda, Kita-ku, Osaka-shi, Osaka |
| Tokyo Clinical Development Center | 6F, ORIX Ueno 1-chome Bldg., 1-1-10 Ueno, Taito-ku, Tokyo, Japan |
| Osaka Clinical Development Center | Mainichi Intecio 18F, 3-4-5 Umeda, Kita-ku, Osaka-shi, Osaka |
| Synthesis Laboratory | IRC CHEMICAL |
| Oversea Office | Taiwan Representative Office (Taipei, ROC) |
| Number of Employee | 159 (as of October1, 2012) |
| Establishment | August 2005 |
| Capital | 60 Million yen |
| President & CEO | Masakuni Ukita |
| Membership |
Osaka Pharmaceutical Manufacturers Association Japan Society of Quality Assurance Japan CRO Association |
| Corporate Philosophy | “Through Science and Technology, we will provide valuable innovation to the world” |
| Scope of Business |
・Drug Development Services ・Medical Device Development Services ・Research & Development Services |
Osaka Headquarter
Tokyo Branch
